Immutep Limited (IMMP) Income Statement

NASDAQ: IMMPRevenue, profits, margins and EPS over 10 years.

IMMP FY2026 at a glance

Fiscal year ended June 30, 2026 · Australian dollars
Revenue+182.3%
A$14.2M
FY2026 · hover or tap a bar for each year
FY2017: A$4.2M (+2,311.6%)FY2018: A$2.6M (−37.7%)FY2019: A$139,782 (−94.7%)FY2020: A$7.5M (+5,255.8%)FY2021: A$3.9M (−48.4%)FY2022: A$170,369 (−95.6%)FY2023: A$3.5M (+1,957.7%)FY2024: A$3.8M (+9.6%)FY2025: A$5.0M (+31.3%)FY2026: A$14.2M (+182.3%)
FY2017FY2026
Gross profit
A$11.8M
FY2026 · hover or tap a bar for each year
FY2017: A$2.5MFY2018: −A$7.4M (−392.0%)FY2019: −A$16.5MFY2020: −A$15.0MFY2021: −A$13.4MFY2022: −A$1.9MFY2023: A$1.4MFY2024: −A$37.7M (−2,711.3%)FY2025: −A$56.4MFY2026: A$11.8M
FY2017FY2026
Operating income
−A$82.0M
FY2026 · hover or tap a bar for each year
FY2017: −A$9.4MFY2018: −A$11.7MFY2019: −A$20.4MFY2020: −A$16.0MFY2021: −A$31.7MFY2022: −A$33.9MFY2023: −A$77.7MFY2024: −A$88.1MFY2025: −A$126.4MFY2026: −A$82.0M
FY2017FY2026
Net income
−A$77.6M
FY2026 · hover or tap a bar for each year
FY2017: −A$9.4MFY2018: −A$12.7MFY2019: −A$16.3MFY2020: −A$13.5MFY2021: −A$29.9MFY2022: −A$32.2MFY2023: −A$39.9MFY2024: −A$42.7MFY2025: −A$61.4MFY2026: −A$77.6M
FY2017FY2026
Net profit margin+673.2 pts
−544.8%
FY2026 · hover or tap a point for each year
FY2017: −221.9% (+35,204.8 pts)FY2018: −484.6% (−262.7 pts)FY2019: −11,640.0% (−11,155.5 pts)FY2020: −179.9% (+11,460.1 pts)FY2021: −774.1% (−594.2 pts)FY2022: −18,906.5% (−18,132.4 pts)FY2023: −1,138.0% (+17,768.5 pts)FY2024: −1,111.9% (+26.2 pts)FY2025: −1,218.0% (−106.2 pts)FY2026: −544.8% (+673.2 pts)
FY2017FY2026

IMMP revenue and net income

RevenueNet incomeNet margin (right axis)

Where IMMP's revenue goes

FY2026
Revenue
A$14.2M100.0%
Cost of revenue
−A$2.4M−17.0%
Gross profit
A$11.8M83.0%
Research & development
−A$75.0M−526.6%
Sales, general & admin
−A$9.6M−67.3%
Other operating expenses
−A$9.3M−65.3%
Operating income
−A$82.0M−576.2%
Interest & other income
A$4.5M31.4%
Net income
−A$77.6M−544.8%

Each bar shows an amount and its share of revenue. IMMP kept −544.8% of revenue as net income.

IMMP profit margins

GrossOperatingNet

IMMP growth rates

to FY2026
1 year3 years5 years10 years
Revenue+182.3%+59.6%+29.8%+55.2%
Gross profit—+101.5%——
Operating income————
Net income————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

IMMP income statement in Australian dollars

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$14.2MA$5.0MA$3.8MA$3.5MA$170,369A$3.9MA$7.5MA$139,782A$2.6MA$4.2M
Cost of revenueA$2.4MA$61.4MA$41.5MA$2.1MA$2.1MA$17.2MA$22.5MA$16.6MA$10.0MA$1.7M
Gross profitA$11.8M−A$56.4M−A$37.7MA$1.4M−A$1.9M−A$13.4M−A$15.0M−A$16.5M−A$7.4MA$2.5M
Research & developmentA$75.0MA$61.4MA$41.5MA$28.8MA$31.3MA$17.2MA$20.4MA$16.6MA$10.0MA$7.5M
Sales, general & adminA$9.6MA$8.6MA$8.9MA$14.1MA$7.2MA$6.3MA$6.3MA$6.1MA$7.2MA$4.3M
Total operating expensesA$93.9MA$70.1MA$50.4MA$44.9MA$32.5MA$18.3MA$22.6MA$19.1MA$14.8MA$9.5M
Operating income−A$82.0M−A$126.4M−A$88.1M−A$77.7M−A$33.9M−A$31.7M−A$16.0M−A$20.4M−A$11.7M−A$9.4M
Interest incomeA$3.0M—A$3.9MA$938,999A$326,380A$105,327A$199,541A$397,281A$177,186A$104,368
Interest expenseA$66,411A$24,012A$30,594A$20,401A$92,430A$9,825A$10,457A$0A$0A$0
Income before taxes−A$77.6M−A$61.4M−A$42.7M−A$39.9M−A$32.2M−A$29.9M−A$13.5M−A$18.3M−A$12.7M−A$10.1M
Income taxes——A$2A$2A$34A$33A$37−A$2.1MA$1,676−A$737,387
Net income−A$77.6M−A$61.4M−A$42.7M−A$39.9M−A$32.2M−A$29.9M−A$13.5M−A$16.3M−A$12.7M−A$9.4M
EBITDA−A$79.6M−A$62.5M−A$44.4M−A$39.4M−A$31.8M−A$17.6M−A$11.4M−A$16.5M−A$10.4M−A$8.4M
Gross margin83.0%−1,117.6%−981.4%41.2%−1,111.2%−346.2%−200.2%−11,769.3%−279.8%59.7%
Operating margin−576.2%−2,506.5%−2,293.3%−2,216.0%−19,920.0%−820.0%−214.0%−14,606.5%−444.5%−221.5%
Net margin−544.8%−1,218.0%−1,111.9%−1,138.0%−18,906.5%−774.1%−179.9%−11,640.0%−484.6%−221.9%

Quarterly columns are labeled by the month the quarter ended. Figures in Australian dollars as reported in IMMP's financial statements (latest annual report filed June 30, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

IMMP financial results

In fiscal year 2026 (ended June 30, 2026), Immutep reported revenue of A$14.2 million, up 182.3% from the year before. It had a net loss of A$77.6 million, a net profit margin of −544.8%. Over five years revenue grew at an average rate of 29.8% a year. Figures are in Australian dollars, the currency of its financial statements.

See the IMMP stock overview for the latest quote and news, or the IMMP chart for price history and technical indicators.

IMMP income statement FAQ

What is Immutep's annual revenue?

Immutep reported total revenue of A$14.2 million for fiscal year 2026, which ended on June 30, 2026. That was up 182.3% from A$5.0 million the previous year.

Is Immutep profitable?

No. Immutep reported a net loss of A$77.6 million in fiscal 2026, a net profit margin of −544.8%; its operating margin was −576.2%.

What is Immutep's gross margin?

Immutep's gross margin was 83.0% in fiscal 2026: for every $100 of revenue, Immutep kept $83 after the direct cost of its products and services.

How much does Immutep spend on research and development?

Immutep spent A$75.0 million on research and development in fiscal 2026, 526.6% of revenue.

How fast is Immutep growing?

Revenue grew 29.8% a year on average over the last five fiscal years, from A$3.9 million to A$14.2 million.

When does Immutep's fiscal year end?

Immutep's fiscal year ends in June. The latest annual report covers the year ended June 30, 2026 and was filed on June 30, 2026.

Biotechnology income statements